Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SCN1A | P35498 | 1/20 | 0.30 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.30 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.30 |
| ▸ | EBP | Q15125 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21981138 | 0.81 | MEN1 (0.35) | MEN1KMT2ATDP1POLBGAA | |
| SCHEMBL28525785 | 0.80 | TDP1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL955824 | 0.79 | MEN1 (0.34) | MEN1KMT2APOLBGAACYP2C9 | |
| SCHEMBL22733778 | 0.76 | LPAR3 (0.48) | MEN1KMT2APOLBLMNAEBP | |
| SCHEMBL3826872 | 0.75 | TDP1 (0.56) | MEN1KMT2ATDP1POLBGAA | |
| SCHEMBL5961193 | 0.70 | CYP3A4 (0.48) | MEN1KMT2APOLBGAACYP2C9 | |
| SCHEMBL1604996 | 0.70 | MEN1 (0.54) | MEN1KMT2ATDP1 | |
| SCHEMBL16660508 | 0.69 | CYP3A4 (0.39) | MEN1KMT2APOLBSCN1ASCN2A | |
| SCHEMBL16482959 | 0.68 | KMT2A (0.39) | MEN1KMT2APOLBGAACYP2C9 | |
| SCHEMBL4564740 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102459604-B | DFP enzyme from California sea rabbits | 诺维信公司 | 2016-08-17 | — | — | CN | claimed |
| US-11325100-B2 | Bisphenol hypersorbents for enhanced detection of, or protection from, hazardous chemicals | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2022-05-10 | — | — | US | disclosed |
| US-20190134601-A1 | BISPHENOL HYPERSORBENTS FOR ENHANCED DETECTION OF, OR PROTECTION FROM, HAZARDOUS CHEMICALS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2019-05-09 | — | — | US | disclosed |
| CN-106434596-A | DFPASE ENZYMES FROM APLYSIA CALIFORNICA | 诺维信公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-102459604-B | DFP enzyme from California sea rabbits | 诺维信公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-102459604-A | DFP enzyme from California sea rabbits | NOVOZYMES AS | 2012-05-16 | — | — | CN | disclosed |
| CN-102414316-A | DFP enzyme from octopus vulgaris | NOVOZYMES AS | 2012-04-11 | — | — | CN | disclosed |
| US-20100168030-A1 | Methods and compositions for treatment of organophosphate-caused pathology | ARMY, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190134601-A1 | BISPHENOL HYPERSORBENTS FOR ENHANCED DETECTION OF, OR PROTECTION FROM, HAZARDOUS CHEMICALS | SHBG, GSTP1, GSTA2 | MEN1 4724/4885KMT2A 3547/4885TDP1 3150/4885 |
| US-11325100-B2 | Bisphenol hypersorbents for enhanced detection of, or protection from, hazardous chemicals | SHBG, GSTP1, GSTA2 | MEN1 4724/4885KMT2A 3547/4885TDP1 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.